SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vernalis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: nigel bates10/3/2007 7:30:50 AM
  Read Replies (1) of 20
 
Vernalis says executive chairman Peter Fellner lifts stake in co to 0.133 pct

LONDON (Thomson Financial) - Specialty drug company Vernalis PLC (LSE: VER.L - news) said executive chairman Peter Fellner has bought 252,000 shares at 16.25 pence each, lifting his stake to 415,888 shares or 0.133 pct of the company's issued share capital.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News